Overexpression of transferrin receptor and ferritin related to clinical symptoms and destabilization of human carotid plaques

Experimental Biology and Medicine

Volumn 233, Issue 7, 2008, Pages 818-826

  Li, Wei ^a   Xu, Li Hua ^a,c   Forssell, Claes ^a   Sullivan, Jerome L ^b   Yuan, Xi Ming ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

^c BEIHUA UNIVERSITY   (China)

Author keywords

Apoptosis; Atherosclerosis; Iron metabolism; Lysosomes; Macrophages; Plaque rupture

Indexed keywords

CATHEPSIN L; CD71 ANTIGEN; FERRITIN; CATHEPSIN; CD68 ANTIGEN, HUMAN; CYSTEINE PROTEINASE; DIFFERENTIATION ANTIGEN; IRON; LEUKOCYTE ANTIGEN; TRANSFERRIN RECEPTOR;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; IRON METABOLISM; IRON TRANSPORT; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RISK FACTOR; SMOOTH MUSCLE FIBER; ATHEROSCLEROSIS; CAROTID ARTERY OBSTRUCTION; GENE EXPRESSION REGULATION; GENETICS; HOSPITALIZATION; LYSOSOME; METABOLISM; MIDDLE AGED; PATHOLOGY; VASCULAR SMOOTH MUSCLE;

AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ATHEROSCLEROSIS; CAROTID STENOSIS; CATHEPSINS; CYSTEINE ENDOPEPTIDASES; FEMALE; FERRITINS; GENE EXPRESSION REGULATION; HUMANS; IRON; LYSOSOMES; MACROPHAGES; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, TRANSFERRIN; SEVERITY OF ILLNESS INDEX;

EID: 47749122193     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0711-RM-320     Document Type: Article

References (38)

1. Ramakrishna G, Rooke TW, Cooper LT. Iron and peripheral arterial disease: revisiting the iron hypothesis in a different light. Vasc Med 8:203-210, 2003.
2. Yuan XM, Li W. The iron hypothesis of atherosclerosis and its clinical impact. Ann Med 35:578-591, 2003.
3. Chen L, Xiong S, She H, Lin SW, Wang J, Tsukamoto H. Iron causes interactions of TAK1, p21ras, and phosphatidylinositol 3-kinase in caveolae to activate IκB kinase in hepatic macrophages. J Biol Chem 282:5582-5588, 2007.
4. Pang JH, Jiang MJ, Chen YL, Wang FW, Wang DL, Chu SH, Chau LY. Increased ferritin gene expression in atherosclerotic lesions. J Clin Invest 97:2204-2212, 1996.
5. Yuan XM. Apoptotic macrophage-derived foam cells of human atheromas are rich in iron and ferritin, suggesting iron-catalysed reactions to be involved in apoptosis. Free Rad Res 30:221-231, 1999.
6. Li W, Hellsten A, Xu LH, Zhuang DM, Jansson K, Brunk UT, Yuan XM. Foam cell death induced by 7beta-hydroxycholesterol is mediated by labile iron-driven oxidative injury: mechanisms underlying induction of ferritin in human atheroma. Free Radic Biol Med 39:864-875, 2005.
7. Kolodgie FD, Narula J, Burke AP, Haider N, Farb A, Hui-Liang Y, Smialek J, Virmani R. Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death. Am J Pathol 157:1259-1268, 2000.
8. Lee TS, Shiao MS, Pan CC, Chau LY. Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice. Circulation 99:1222-1229, 1999.
9. Lee HT, Chiu LL, Lee TS, Tsai HL, Chau LY. Dietary iron restriction increases plaque stability in apolipoprotein-E-deficient mice. J Biomed Sci 10:510-517, 2003.
10. Minqin R, Rajendran R, Pan N, Tan BK, Ong WY, Watt F, Halliwell B. The iron chelator desferrioxamine inhibits atherosclerotic lesion development and decreases lesion iron concentrations in the cholesterol-fed rabbit. Free Radic Biol Med 38:1206-1211, 2005.
11. Daniels TR, Delgado T, Rodriguez JA, Helguera G, Penichet ML. The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin Immunol 121:144-158, 2006.
12. Kidane TZ, Sauble E, Linder MC. Release of iron from ferritin requires lysosomal activity. Am J Physiol Cell Physiol 291:C445-455, 2006.
13. Wen Y, Leake DS. Low density lipoprotein undergoes oxidation within lysosomes in cells. Circ Res 11:1337-1343, 2007.
14. Virmani R, Ladich ER, Burke AP, Kolodgie FD. Histopathology of carotid atherosclerotic disease. Neurosurgery 59:S219-227; discussion S3-13, 2006.
15. Hallerstam S, Larsson PT, Zuber E, Rosfors S. Carotid atherosclerosis is correlated with extent and severity of coronary artery disease evaluated by myocardial perfusion scintigraphy. Angiology 55:281-288, 2004.
16. Lehr HA, Mankoff DA, Corwin D, Santeusanio G, Gown AM. Application of Photoshop-based image analysis to quantification of hormone receptor expression in breast cancer. J Histochem Cytochem 45:1559-1565, 1997.
17. Andreesen R, Osterholz J, Bodemann H, Bross KJ, Costabel U, Lohr GW. Expression of transferrin receptors and intracellular ferritin during terminal differentiation of human monocytes. Blut 49:195-202, 1984.
18. Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK, Farb A, Guerrero LJ, Hayase M, Kutys R, Narula J, Finn AV, Virmani R. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 349:2316-2325, 2003.
19. Testa U, Petrini M, Quaranta MT, Pelosi-Testa E, Mastroberardino G, Camagna A, Boccoli G, Sargiacomo M, Isacchi G, Cozzi A. Iron up-modulates the expression of transferrin receptors during monocyte-macrophage maturation. J Biol Chem 264:13181-13187, 1989.
20. Seiser C, Teixeira S, Kuhn LC. Interleukin-2-dependent transcriptional and post-transcriptional regulation of transferrin receptor mRNA. J Biol Chem 268:13074-13080, 1993.
21. Tsuji Y, Miller LL, Miller SC, Torti SV, Torti FM. Tumor necrosis factor-alpha and interleukin 1-alpha regulate transferrin receptor in human diploid fibroblasts. Relationship to the induction of ferritin heavy chain. J Biol Chem 266:7257-7261, 1991.
22. Taetle R, Honeysett JM. Gamma-interferon modulates human mono-cyte/macrophage transferrin receptor expression. Blood 71:1590-1595, 1988.
23. 2 and not superoxide determines the compartment-specific activation of trans-ferrin receptor by iron regulatory protein 1. Free Radic Res 39:817-824, 2005.
24. Li W, Dalen H, Eaton JW, Yuan XM. Apoptotic death of inflammatory cells in human atheroma. Arterioscler Thromb Vasc Biol 21:1124-1130, 2001.
25. Kitamoto S, Sukhova GK, Sun J, Yang M, Libby P, Love V, Duramad P, Sun C, Zhang Y, Yang X, Peters C, Shi GP. Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice. Circulation 115:2065-2075, 2007.
26. Weaver DJ, Jr., Voss EW, Jr. Kinetics and intracellular pathways required for major histocompatibility complex II-peptide loading and surface expression of a fluorescent hapten-protein conjugate in murine macrophage. Immunology 96:557-568, 1999.
27. Li W, Yuan XM, Olsson AG, Brunk UT. Uptake of oxidized LDL by macrophages results in partial lysosomal enzyme inactivation and relocation. Arterioscler Thromb Vasc Biol 18:177-184, 1998.
28. Yuan XM, Li W, Brunk UT, Dalen H, Chang YH, Sevanian A. Lysosomal destabilization during macrophage damage induced by cholesterol oxidation products. Free Radic Biol Med 28:208-218, 2000.
29. Yuan XM, Li W, Olsson AG, Brunk UT. The toxicity to macrophages of oxidized low-density lipoprotein is mediated through lysosomal damage. Atherosclerosis 133:153-161, 1997.
30. Sakurai K, Nabeyama A, Fujimoto Y. Ascorbate-mediated iron release from ferritin in the presence of alloxan. Biometals 19:323-333, 2006.
31. Ohishi K, Zhang XM, Moriwaki S, Hiramitsu T, Matsugo S. Iron release analyses from ferritin by visible light irradiation. Free Radic Res 39:875-882, 2005.
32. Harrison PM, Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1275:161-203, 1996.
33. Lapenna D, Pierdomenico SD, Ciofani G, Ucchino S, Neri M, Giamberardino MA, Cuccurullo F. Association of body iron stores with low molecular weight iron and oxidant damage of human atherosclerotic plaques. Free Radic Biol Med 42:492-498, 2007.
34. Stadler N, Lindner RA, Davies MJ. Direct detection and quantification of transition metal ions in human atherosclerotic plaques: evidence for the presence of elevated levels of iron and copper. Arterioscler Thromb Vasc Biol 24:949-954, 2004.
35. Yuan XM, Anders WL, Olsson AG, Brunk UT. Iron in human atheroma and LDL oxidation by macrophages following erythropha-gocytosis. Atherosclerosis 124:61-73, 1996.
36. Lepelletier Y, Camara-Clayette V, Jin H, Hermant A, Coulon S, Dussiot M, Arcos-Fajardo M, Baude C, Canionni D, Delarue R, Brousse N, Benaroch P, Benhamou M, Ribrag V, Monteiro RC, Moura IC, Hermine O. Prevention of mantle lymphoma tumor establishment by routing transferrin receptor toward lysosomal compartments. Cancer Res 67:1145-1154, 2007.
37. Hogemann-Savellano D, Bos E, Blondet C, Sato F, Abe T, Josephson L, Weissleder R, Gaudet J, Sgroi D, Peters PJ, Basilion JP. The transferrin receptor: a potential molecular imaging marker for human cancer. Neoplasia 5:495-506, 2003.
38. Sullivan JL. Macrophage iron, hepcidin, and atherosclerotic plaque stability. Exp Biol Med (Maywood) 232:1014-1020, 2007.